ライフサイエンスコーパス: patient with

1 Treatment use among patients with 0, 1, or 2 FLG loss of function (LOF) alle

2 Patients with 1 or more previous admissions to an urban

3 Patients with 2 FLG LOF alleles were less likely to repo

4 delayed interferon beta-1b treatment in 465 patients with a CIS.

5 Patients with a clinical diagnosis of obstructive HCM re

6 Patients with a diffuse pattern had more features of adv

7 asma profiling after STEMI may help identify patients with a greater likelihood of response to cell-b

8 In this low-risk elderly cohort, 46% of patients with a nonbacterial AURI were prescribed antibi

9 ovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss H

10 mary efficacy endpoint was the percentage of patients with a sustained virologic response 12 weeks af

11 the clinical characteristics and survival of patients with ACOS identified in a real-life cohort of p

12 Most patients with acquired TTP respond to a combination of p

13 he presence of bursitis in more than half of patients with active disease.

14 In pediatric patients with acute appendicitis undergoing appendectomy

15 The authors assessed the incidence of AKI in patients with acute coronary syndrome (ACS) enrolled in

16 ) to assess whether intensive BP lowering in patients with acute ICH is safe and effective in improvi

17 ankin Scale (mRs) >/=3;efficacy outcome), in patients with acute ICH randomised to either intensive B

18 Five eligible studies including 4360 patients with acute ICH were pooled in meta-analysis.

19 ted with less favorable clinical outcomes in patients with acute ischemic stroke caused by intracrani

20 Purpose Elderly patients with acute myeloid leukemia (AML) have a poor p

21 A total of 1,230 patients with acute myocardial infarction (MI) treated w

22 ve ventilation (NIV) is increasingly used in patients with acute respiratory distress syndrome (ARDS)

23 ymptomatic high-grade carotid disease versus patients with acutely symptomatic carotid disease and re

24 d in patients with MCI (mean, 42.8 ng/L) and patients with AD dementia (mean, 51.0 ng/L) compared wit

25 < .001) and had high diagnostic accuracy for patients with AD with dementia vs controls (area under t

26 sutinib at 200 mg/d reduced kidney growth in patients with ADPKD.

27 fect of MABp1 with a new primary endpoint in patients with advanced colorectal cancer.

28 he use of imatinib, in a large population of patients with advanced GIST.

29 The authors randomized 150 patients with advanced HF between August 15, 2012, and J

30 redictors of prognosis in chemotherapy-naive patients with advanced NSCLC, we recruited all those who

31 Only 40% of patients with advanced ovarian cancer survive more than

32 LL05 trial confirms the favorable outcome of patients with advanced-stage FL treated with immunochemo

33 For the average patient with AF, the threshold of annual ischemic stroke

34 ence and relative risk of AF in relatives of patients with AF, as well as the relative contributions

35 y detection and improved visual outcomes for patients with age-related macular degeneration.

36 on the Emergency department Spanish Score In patients with AHF) score.

37 e randomized crossover study in nonintubated patients with AHRF with PaO2/setFiO2 less than or equal

38 s known about the relevance of glycolysis in patients with allergic asthma.

39 hy model and in postmortem brain tissue from patients with alpha-synucleinopathy.

40 more from complement-inhibiting therapy than patients with AMD in general.

41 Of the 43249 patients with AML (mean [SD] age, 59.5 [16.6] years; 239

42 We have demonstrated that patients with AML exhibit increased presence of MDSCs in

43 in vitro and evaluated their impact in 1,328 patients with AML who underwent HCT from 9/10 or 10/10 H

44 s well as in retrospective analyses of adult patients with AML, the response to Ara-C-containing ther

45 icance of CNA presence in disease relapse in patients with AML.

46 An initial population of patients with an admission to a medical ICU totaling 10,

47 Results Between diabetic patients with and diabetic patients without DPN, mean ag

48 biota surrounding exposed dental implants in patients with and without a history of periodontitis thr

49 ollowed by a validation study in 30 selected patients with and without delirium (median age, 63 yr; r

50 otic conjunctival fibroblast cell lines from patients with and without previous glaucoma surgery, res

51 In contrast to patients with aortic valve stenosis, MEE was not improve

52 In the six patients with aspiration syndrome after mechanical venti

53 shed regarding the role of the microbiome in patients with asthma, atopic dermatitis, and food allerg

54 commendations for the clinical care of adult patients with astrocytic and oligodendroglial gliomas, i

55 vels of these noncoding RNAs are observed in patients with asymptomatic high-grade carotid disease ve

56 Patients and Methods Eligible patients with at least one prior irinotecan-containing t

57 e to inflammatory manifestations observed in patients with AT, Artemis deficiency, and SAVI.

58 A total of 1585 patients with atrial fibrillation undergoing PVI from th

59 ned from 128 patients with exudative AMD, 46 patients with atrophic AMD and 111 healthy controls.

60 Twenty-seven African American patients and 9 patients with ATTR V122I amyloidosis comprised the valid

61 nts with filamentous fungal keratitis and 24 patients with bacterial keratitis (as controls).

62 1.5-7.2), and 7.3 per 100 person-years among patients with baseline high-grade dysplasia (95% CI 4.2-

63 CI 3.3-8.2); 3.3 per 100 person-years among patients with baseline low-grade dysplasia (95% CI 1.5-7

64 analysis, patients with irregular Z line and patients with BE of >/= 1 cm did not differ significantl

65 In patients with bicuspid aortic valve and dilated proximal

66 o detect prostate cancer (PCa) recurrence in patients with biochemical relapse.

67 of diagnostics and therapeutics for affected patients with bleeding disorders.

68 distal airway brushings were collected from patients with BOS (n = 10), stable lung transplant patie

69 evelopment of treatment solutions to benefit patients with breast cancer at high risk of recurrence.

70 or depression constitute a large subgroup of patients with breast cancer who are at risk for receivin

71 cally designed to evaluate statin therapy in patients with cancer.

72 Patients with cardiogenic shock or cardiac arrest on pre

73 quired to effectively consider and treat all patients with cardiovascular disease.

74 Of these, 47 patients with CCTA examinations were assessed further.

75 Twelve patients with cDGS underwent transplantation with alloge

76 ns in the TUBB4A gene have been described in patients with central nervous system hypomyelination.

77 -) were evaluated using flow cytometry in 32 patients with cGvHD treated by ECP for a minimum of 3 mo

78 w-LVAD database (n=354) was used to identify patients with chest computed tomographies performed in t

79 tion) trial, a clinical trial in which 2,604 patients with chronic angina and incomplete revasculariz

80 ifungal treatment is indicated in almost all patients with chronic cavitary pulmonary infections, chr

81 ide guidance has been extensively studied in patients with chronic heart failure (HF), with only limi

82 on of nucleos(t)ide analog (NA) treatment in patients with chronic hepatitis B (CHB).

83 MR) viscoelastic and diffusion parameters in patients with chronic liver disease and to compare the d

84 differences in individual cytokine levels in patients with chronic liver disease, but comprehensive c

85 ed generation of TH17 cells; meanwhile, some patients with chronic mucocutaneous candidiasis disease

86 amage to protect the host from infections in patients with chronic rhinosinusitis with nasal polyps.

87 d HIPAA-compliant retrospective study, adult patients with cirrhosis and Model for End-Stage Liver Di

88 It is a challenge to treat patients with cirrhosis using anticoagulants, because of

89 Among patients with cirrhosis, statin use decreased the risk o

90 Patients with cleft lip and/or palate (CLP), who undergo

91 ic colorectal cancer has clinical benefit in patients with colorectal liver metastases with liver-dom

92 Everyday visual search can be impaired in patients with common eye diseases like glaucoma and age-

93 The proportion of patients with complete clinical response at day 7 was si

94 20 patients with complete unilateral cleft lip and palate w

95 te the associations and sensitizations among patients with concomitant AD and ACD.

96 OIT may provide an additional OIT option for patients with concurrent PN/TN and other food allergies.

97 A total of 30% to 40% of patients with congestive heart failure eligible for card

98 ith ACOS identified in a real-life cohort of patients with COPD.

99 Nine of 10 BPH and eight of 14 patients with CPr had at least one oral pathogen in thei

100 -basement membrane antibodies than sera from patients with CRSwNP and control subjects (P < .0001).

101 at MUC4 modulates corticosteroid efficacy of patients with CRSwNP.

102 ogy used in 38 cSCC biopsy specimens from 24 patients with cSCC (19 men and 5 women; mean [SD] age, 7

103 calcium oxalate stone formation observed in patients with cystic fibrosis.

104 s with other clinical indications, including patients with diabetes mellitus and prediabetes and thos

105 iabetic retinal disease (2.4 injections/1000 patients with diabetic retinal disease in 2009 to 13.6 p

106 with a change in the incidence of PME among patients with diabetic retinopathy (RR 1.06, 95% 0.81-1.

107 wing improved BCVA after cataract surgery in patients with diabetic retinopathy, with no unanticipate

108 ility, quality of life, and complications in patients with displaced tibial fracture treated with int

109 Patients with documented moderate or severe symptoms and

110 The proportion of patients with documented well-controlled asthma in this

111 All patients with early systolic dysfunction recovered in 1

112 come benefit from adjuvant anthracyclines in patients with early TOP2A-normal breast cancer.

113 e than the P1 implicit time and was lower in patients with Early Treatment of Diabetic Retinopathy St

114 afety of IVT or an estradiol vaginal ring in patients with early-stage BC receiving an AI; secondary

115 Individual data from 2092 patients with enteric fever randomized into 4 trials in

116 llergens were injected in the esophagus of 8 patients with EoE and 3 patients without EoE (controls).

117 titumour activity and objective responses in patients with epithelial malignancies.

118 etinopathy Study (ETDRS) level 20-35 than in patients with ETDRS level <20 (P = 0.005).

119 ose Significantly improved survival rates in patients with Ewing sarcoma have raised interest in acce

120 Plasma was obtained from 128 patients with exudative AMD, 46 patients with atrophic A

121 rosis stage, but was cost-effective only for patients with F3 fibrosis; our results highlight the pro

122 clusion, we demonstrate a relevant number of patients with FDG-PET false-negative MM and a strong ass

123 This study included 21 patients with filamentous fungal keratitis and 24 patien

124 Patients with first-episode psychosis had lower regional

125 The proportion of patients with genital infections was greater with empagl

126 mber 30, 2016, and included both eyes of 100 patients with glaucoma or ocular hypertension.

127 duced mortality and increased proportions of patients with good recovery compared with intracranial p

128 the 2006 Massachusetts insurance expansion, patients with government-subsidized or self-pay insuranc

129 rates and prognostic factors for survival in patients with HCM.

130 ting budget impact between ECHO and non-ECHO patients with HCV were then compared.

131 cy and safety of sublingual immunotherapy in patients with HDM-induced AA and AR, their effect on sub

132 Although beta-blockers increase survival in patients with heart failure (HF), the mechanisms behind

133 nique and novel strategies for Management of Patients with Heart failure [TRIUMPH]; NTR1893).

134 osin activators, are under investigation for patients with heart failure with reduced left ventricula

135 onic inflammatory diseases, such as COPD, in patients with hemoptysis, TAE of the BAA and of the path

136 ormed a multicenter prospective study of 226 patients with hepatitis C virus-associated cirrhosis and

137 ficantly up-regulated in CD8(+) T cells from patients with hepatitis delta.

138 is double-blinded, placebo-controlled trial, patients with HER2-positive early breast cancer were ran

139 re associated with functional improvement in patients with HF and reduced ejection fraction receiving

140 ection are not fully understood, and not all patients with HF respond favorably to them.

141 anagement reduces morbidity and mortality in patients with HFrEF on GDMT, underscoring the important

142 Patients with high BCL2 expression had a higher ORR (94%

143 e precursor cell differentiation observed in patients with high remyelination pattern.

144 en, and ruxolitinib might extend survival of patients with higher-risk myelofibrosis.

145 ic overuse occurred in 24.1% (n = 163451) of patients, with highest rates among those receiving intra

146 A total of 330 patients with history of ASA sensitivity with known/susp

147 rtic valve stenosis, MEE was not improved in patients with HOCM after surgery, which was explained by

148 Of the 47690 patients with HS (26.2% men and 73.8% women), the overal

149 The study comprised 7,732 patients with HS and 4,354,137 subjects from the general

150 Patients with hypertriglyceridemia who were taking gemfi

151 rences in CAL and PD compared with untreated patients with hypertriglyceridemia.

152 Double mutations in patients with hypertrophic cardiomyopathy are much less

153 lable data suggests that double mutations in patients with hypertrophic cardiomyopathy are not rare a

154 Based on this cutoff, 36.2% of patients with IBD in mucosal healing have increased inte

155 nally, we confirmed low 25D plasma levels in patients with IBD with active inflammation.

156 increased in inflamed intestinal tissues of patients with IBD.

157 The overall response rate for patients with IMT (treated at 100, 165, and 280 mg/m(2)/

158 A total of 207 patients with incidentally discovered gallbladder cancer

159 ary analysis of the RIVER-PCI (Ranolazine in Patients with Incomplete Revascularization after Percuta

160 he airways of prednisone-dependent asthmatic patients with increased eosinophil activity, recurrent p

161 Rooms from which a patient with infection or colonisation with a target org

162 e SOFA and qSOFA classifications to identify patients with infection who are at elevated risk of poor

163 ng by allergists to offer BLAST for eligible patients with infectious diseases receiving nonpreferred

164 implication was studied in blood samples of patients with inflammatory bowel disease (IBD) receiving

165 We included 3376 patients with influenza A(H1N1)pdm09, of whom 3085 (91.4

166 Recently, DES mutations were described in patients with inherited arrhythmogenic right ventricular

167 In patients with initial normal lactate (< 2.2 mmol/L), ele

168 tibular function and surgical specimens from patients with intractable Meniere's disease.

169 On multivariate analysis, patients with irregular Z line and patients with BE of >

170 ive, multicenter cohort study, we found that patients with irregular Z line do not develop HGD or eso

171 e outcomes of use of thrombolytic therapy in patients with ischemic stroke who received anticoagulati

172 Patients with isolated focal dystonia evaluated within 5

173 Although patients with isoniazid-resistant tuberculosis had a hig

174 for prevention of squamous cell carcinoma in patients with Kindler syndrome.

175 which 124 (33.6%) were in non-anticoagulated patients with known prior AF.

176 nt loss to follow-up) between the numbers of patients with laboratory-confirmed RR-TB and those repor

177 The remaining 5 patients with late recurrent viremia had virologic relap

178 In patients with long-term aspirin use, the changes of mole

179 pression had a higher ORR (94% [17/18]) than patients with low BCL2 expression (59% [16/27]).

180 ncer Genome Atlas database (TCGA) found that patients with lower expression of POU2F2 and higher expr

181 ted a retrospective study comprising the 606 patients with LQTS (LQT1 in 47%, LQT2 in 34%, and LQT3 i

182 One hundred fifteen patients with lung lesions were then prospectively inclu

183 Patients with lung or colorectal cancer often exhibit le

184 ve analysis was conducted of 115 consecutive patients with lymphomas (45 females, 70 males; mean age

185 uring and progresses during interruptions in patients with macula-on RD.

186 Patients with major depressive disorder completed two rt

187 ogic Versus Pharmacologic Treatment of Adult Patients with Major Depressive Disorder." The evidence r

188 our spatial approach to a set of images from patients with malarial retinopathy, and found it compare

189 s with type 2 diabetes, as has been shown in patients with maturity onset diabetes of the young.

190 Plasma NFL was increased in patients with MCI (mean, 42.8 ng/L) and patients with AD

191 nsion cohorts were initiated at 3.0 mg/kg in patients with melanoma (n = 16) and renal cell carcinoma

192 expression measured immunohistochemically in patients with metastatic breast cancer.

193 response of bone metastases to treatment in patients with metastatic castration-resistant prostate c

194 mor progression and reduced survival time of patients with metastatic colorectal cancer.

195 r recurrence was significantly increased for patients with metastatic disease (adjusted hazard ratio

196 pply ichorCNA to 1439 blood samples from 520 patients with metastatic prostate or breast cancers.

197 improving survival and quality of life among patients with MI.

198 ffectiveness ratios for surgery in all F0-F3 patients with mild, moderate, or severe obesity were $48

199 ), with harm increasing with PaO2/FiO2 among patients with mild-moderate ARDS, and the possibility of

200 For patients with MPNs, detection of the BCR-ABL1 fusion del

201 17 patients with MS and 11 healthy controls (HCs) underwent

202 medical treatment; p = 0.004), especially in patients with multiple organ failure (acute-on-chronic l

203 urons and oligodendrocytes in the putamen of patients with multiple system atrophy.

204 pacritinib versus best available therapy in patients with myelofibrosis irrespective of baseline cyt

205 i-VEGF drug for the hundreds of thousands of patients with nAMD treated each year worldwide.

206 both effective and cost-effective for obese patients with NASH, regardless of fibrosis stage; in ove

207 e heterogeneity of presenting symptoms among patients with NETs might permit more tailored assessment

208 Using information from deep sequencing of patients with neurological or psychiatric disorders, we

209 onclusion Percent uninsured among nonelderly patients with newly diagnosed cancer declined substantia

210 iopsies and blood samples were obtained from patients with newly diagnosed cardiomyopathy and clinica

211 A stratified random sample of 863 patients with newly diagnosed SCC of the oral cavity, or

212 I has increased markedly, particularly among patients with non-ST elevation myocardial infarction (NS

213 accurately, mild liver fibrosis in pediatric patients with nonalcoholic fatty liver disease.

214 ents aged 5-18 years and appropriate control patients with nonpathologic MR neuroimaging findings (an

215 Among 91330 patients with nonvalvular atrial fibrillation (mean age,

216 troke prevention alternative to warfarin for patients with nonvalvular atrial fibrillation.

217 tis B virus (HBV) e antigen-positive viremic patients with normal liver function and the incorporatio

218 gnostic information, with low event rates in patients with normal myocardial perfusion.

219 icacy and safety of ceftazidime-avibactam in patients with nosocomial pneumonia, including ventilator

220 y inserting a point mutation identified in a patient with NSCL/P.

221 Materials and Methods A cohort of 113 patients with NSCLC diagnosed between April 2008 and Sep

222 FFR into the decision-making process of ACS patients with obstructive coronary artery disease is ass

223 tive and well tolerated for the treatment of patients with ocular hypertension and open-angle glaucom

224 er of cerebral and systemic vascular risk in patients with OSA requiring further comprehensive invest

225 ecommendations, when data are available, for patients with other clinical indications, including pati

226 rican, East or South Asian Canadians and for patients with "other" ethnic background, respectively.

227 All 939 patients with out-of-hospital cardiac arrest of presumed

228 ing use of emergency departments among older patients with palliative needs has led to the developmen

229 genome sequencing of 26 metastases from four patients with pancreatic cancer.

230 Patients with pancreatic-insufficient cystic fibrosis (P

231 bjects with mild cognitive impairment (MCI), patients with Parkinson disease (PD), and young and olde

232 pa-induced dyskinesias occur in up to 80% of patients with Parkinson's after a few years of chronic t

233 MMSE] </=25) using data from nine cohorts of patients with Parkinson's disease from North America and

234 evaluation, and treatment of immunocompetent patients with PCNSL.

235 atively recorded single unit activity in ten patients with PD who performed repetitive feet or hand m

236 One hundred and fifty-six patients with PDR-related complications requiring PPV we

237 Patients with periodontitis, especially those who smoke,

238 Thirty-day mortality was comparable among patients with PMI not fulfilling any other of the additi

239 ove the 90th percentile for the 5-mg dose in patients with preserved renal function.

240 e outcome of all (n = 95) renal transplanted patients with pretransplant cancer diagnoses in the Upps

241 events, we update prior recommendations for patients with prevalent coronary heart disease, and we o

242 We examined the proportion of patients with prevalent ESRD in each facility referred f

243 Up to 70% of patients with primary biliary cholangitis develop prurit

244 ost-effective initial localization study for patients with primary hyperparathyroidism.

245 Among patients with prior stent implantation, VLST was causal

246 husetts and the control states compared with patients with private insurance.

247 All patients with probable IA were repeatedly positive for b

248 umulative incidence of epilepsy was lower in patients with prolonged febrile seizures (14.3%, 6.3-29.

249 ve cholangiocytes, in both murine models and patients with PSC.

250 Patients with psoriasis have an increased risk of myocar

251 ory response in healthy subjects, as well as patients with psoriasis or eczema.

252 a link between mucosal and joint immunity in patients with RA.

253 In patients with radiographic evidence of metastases and mi

254 In approximately 50% of patients with RCDII, these Lin(-)IELs develop into a lym

255 ted carotid plaque (68)Ga-DOTATATE uptake in patients with recent carotid events, assessed inter- and

256 Compared with controls, patients with recent STEMI exhibited increased LV wall a

257 In patients with recurrent nasal polyposis receiving topica

258 asting findings were reported in primary APS patients with regard to the increased number of plaques

259 ociated with inferior outcomes after ASCT in patients with rel/ref DLBCL.

260 Novel therapies are needed for patients with relapsed or refractory multiple myeloma (M

261 d comparison of two proteasome inhibitors in patients with relapsed or refractory multiple myeloma.

262 Transplant-eligible patients with relapsed/refractory HL received 2 (cohort

263 Patients with relapsing-remitting MS (RRMS) or clinicall

264 Patients with repetitive ventricular tachycardia/ventric

265 nd molecular genetic findings in a series of patients with RP with likely pathogenic variants in CNGB

266 tion might represent interacting pathways in patients with SA.

267 y that individual tests correctly identified patients with sarcoidosis.

268 ble-blind, placebo-controlled trial included patients with schizophrenia, schizoaffective disorder, o

269 ing of antibiotics to improve the outcome of patients with sepsis.

270 Patients with severe extracranial injuries (AIS >/= 3),

271 MARS was used to support patients with severe liver trauma (SLT), in ALF patients

272 CTE) in the detection of hepatic fibrosis in patients with severe to morbid obesity.

273 Among patients with SHFM-predicted annual mortality </=5.7%, t

274 reduce need for parenteral support volume in patients with short bowel syndrome (SBS) with intestinal

275 findings were similar when including all 210 patients with site-reported paired FFR data.

276 In patients with ST-segment elevation myocardial infarction

277 Patients with stable asthma exhibited exaggerated capsai

278 Among ICU patients with stable renal function, the benefit of usin

279 Data on 17600 patients with stage II to III rectal adenocarcinoma from

280 itivity cardiac troponin I concentrations in patients with suspected acute coronary syndrome in which

281 Patients with systemic mastocytosis (SM) may suffer from

282 Decreased SST-IR neurons in the amygdala of patients with SZ and BD, interpreted here as decreased S

283 vascular morphology was evident in pediatric patients with T1D after one-year's poor glycemic control

284 major adverse cardiovascular outcomes among patients with T1DM.

285 uses of persistent postoperative seizures in patients with temporal lobe epilepsy.

286 Patients with testing ordered for C. difficile were enro

287 Patients with the CC genotype had significantly lower re

288 Gene therapy for patients with this disorder is complicated by the comple

289 Three patients with treated retinoblastoma who developed sever

290 te, 58%), but its use should be reserved for patients with truly severe and refractory LyP.

291 Also, long-term follow-up of patients with TTP is crucial to identify the occurrence

292 luate real-world effectiveness and safety in patients with type 1 hepatorenal syndrome.

293 associated with cognitive function in older patients with type 2 diabetes who are carriers of the ha

294 in more specific and tailored management of patients with type 2 diabetes, as has been shown in pati

295 trial (TACE 2) in 20 hospitals in the UK for patients with unresectable, liver-confined hepatocellula

296 ient, and no residual MR in the remaining 26 patients with valves in situ.

297 nd the possibility of decreased mortality in patients with very severe ARDS.

298 5 m/s at the time of AS diagnosis identifies patients with very severe AS at high risk of death.

299 Conclusion Patients with WDTC treated with RAI had an increased ear

300 opment of improved regenerative medicine for patients with white matter disorders.